Update on the endorsement of CONSORT by high impact factor journals: a survey of journal

David Moher; Kenneth F. Schulz; Sally Hopewell; Larissa Shamseer; Douglas G. Altman

doi:10.17615/tyxz-9y57

Abstract

1 min read

The CONsolidated Standards Of Reporting Trials (CONSORT) Statement provides a minimum standard set of items to be reported in published clinical trials; it has received widespread recognition within the biomedical publishing community. This research aims to provide an update on the endorsement of CONSORT by high impact medical journals.We performed a cross-sectional examination of the online

Related publications

Article2020

CONSORT Statement for Randomized Trials of Nonpharmacologic Treatments: A 2017 Update and a CONSORT Extension for Nonpharmacologic Trial Abstracts

Robert Golub, Nancy C. Chescheir, Philippe Ravaud, Pierre A. Clavien, Trish Groves, Paul Glasziou, Jeremy Grimshaw, Cynthia D. Mulrow, Paula P. Schnurr, Peter McCulloch, Isabelle Boutron, David Moher, David L. Schriger, David Torgerson, Larissa Shamseer, Joseph S. Ross, Douglas G. Altman, Virginia Barbour, Sarah E Lamb, Markus K. Diener, Sally Hopewell, Daniel L. Riddle, Kamaldeep Bhui, Kenneth F. Schulz

Article2017

CONSORT Statement for Randomized Trials of Nonpharmacologic Treatments: A 2017 Update and a CONSORT Extension for Nonpharmacologic Trial Abstracts

Isabelle Boutron, Douglas G. Altman, David Moher, Kenneth F. Schulz, Philippe Ravaud

Article2016